Back

Persisting adaptive immunity to SARS-CoV-2 in Lower Austria

Ladage, D.; Harzer, O.; Engel, P.; Winkler, H.; Braun, R.

2021-02-20 infectious diseases
10.1101/2021.02.18.21251551
Show abstract

The prevalence and persistence of adaptive immunity responses following a SARS-CoV-2 infection provides insights into potential population immunity. Adaptive immune responses comprise of antibody-based responses as well as T cell responses mainly addressing viruses and virus-infected human cells, respectively. A comprehensive analysis of both types of adaptive immunity is essential to follow population-based SARS-CoV-2-specific immunity. In this study, we assessed SARS-CoV-2-specific immunoglobulin A (IgA) levels, SARS-CoV-2-specific immunoglobulin G (IgG) levels, and SARS-CoV-2-specific T cell activities in patients who recovered from a COVID-19 infection in spring and autumn 2020. Here we observed a robust and stable SARS-CoV-2-specific adaptive immune response in both groups with persisting IgA and IgG levels as well as stable T cell activity. Moreover, there was a positive correlation of a lasting immune response with the severity of disease. Our data give evidence for a persisting adaptive immune memory, which suggest a continuing immunity for more than six months post infection.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
based on 140 papers
Top 0.1%
17.8%
2
Nature Communications
based on 483 papers
Top 7%
10.7%
3
Viruses
based on 79 papers
Top 0.2%
6.7%
4
Scientific Reports
based on 701 papers
Top 37%
4.9%
5
PLOS ONE
based on 1737 papers
Top 70%
4.7%
6
Clinical & Translational Immunology
based on 14 papers
Top 0.1%
2.9%
7
The Journal of Immunology
based on 19 papers
Top 0.7%
2.4%
50% of probability mass above
8
Journal of Clinical Immunology
based on 11 papers
Top 0.2%
2.4%
9
PLOS Pathogens
based on 35 papers
Top 0.4%
2.4%
10
Frontiers in Medicine
based on 99 papers
Top 8%
2.4%
11
Nature Immunology
based on 14 papers
Top 0.6%
1.9%
12
Nature Medicine
based on 88 papers
Top 6%
1.9%
13
Science Immunology
based on 15 papers
Top 0.6%
1.6%
14
JCI Insight
based on 63 papers
Top 4%
1.6%
15
Cell Reports Medicine
based on 49 papers
Top 3%
1.6%
16
iScience
based on 74 papers
Top 3%
1.6%
17
Clinical Infectious Diseases
based on 219 papers
Top 15%
1.4%
18
Journal of Infection
based on 64 papers
Top 4%
1.4%
19
International Journal of Infectious Diseases
based on 115 papers
Top 11%
1.4%
20
Journal of Medical Virology
based on 95 papers
Top 6%
1.4%
21
mBio
based on 34 papers
Top 3%
0.8%
22
The Journal of Infectious Diseases
based on 137 papers
Top 9%
0.8%
23
Journal of Clinical Investigation
based on 50 papers
Top 3%
0.8%
24
Vaccines
based on 131 papers
Top 5%
0.8%
25
Science Translational Medicine
based on 40 papers
Top 5%
0.7%
26
Journal of Experimental Medicine
based on 10 papers
Top 0.9%
0.7%